Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person Sharp, GW
| Class:Id | Person:264274 |
|---|
| _displayName | Sharp, GW |
|---|
| _timestamp | 2008-03-30 14:25:48 |
|---|
| created | [InstanceEdit:264267] May, B, 2008-03-30 13:15:05 |
|---|
| initial | GW |
|---|
| modified | [InstanceEdit:264407] May, B, 2008-03-30 14:05:39 |
|---|
| surname | Sharp |
|---|
| (author) | [LiteratureReference:264262] Triggering and augmentation mechanisms, granule pools, and biphasic insulin secretion
[LiteratureReference:400054] Both G i and G o heterotrimeric G proteins are required to exert the full effect of norepinephrine on the beta-cell K ATP channel
[LiteratureReference:400064] Protein acylation in the inhibition of insulin secretion by norepinephrine, somatostatin, galanin, and PGE2
[LiteratureReference:400072] Mechanisms of inhibition of insulin release
[LiteratureReference:445581] Identification of the docked granule pool responsible for the first phase of glucose-stimulated insulin secretion
[LiteratureReference:446521] Norepinephrine inhibits glucose-stimulated, Ca2+-independent insulin release independently from its action on adenylyl cyclase |
|---|
|
[Change default viewing format]
|
No pathways have been reviewed or authored by Sharp, GW (264274)
